Background: In the last decade, the microwave ablation catheter specifically for treating lower extremity varicose veins has become popular. However, imited data is available on the efficacy, analysis, and evaluation of endovenous microwave ablation (EMWA) in treating SSV insufficiency. Our objective is to evaluated the feasibility, safety, and 1-year outcomes of EMWA and concomitant foam sclerotherapy of primary small saphenous vein (SSV) insufficiency.
Methods: Our team carried out a single-center, retrospective analysis of 24 patients treated with EMWAand concomitant foam sclerotherapy for primary SSV insufficiency. All operations were performed using a MWA catheter and polidocanol for the trunk and branches of the SSV, respectively. The SSV occlusion rate was assessed at the 6- and 12-month follow-up examinations using duplex ultrasound. Secondary outcomes included the Clinical, Etiological, Anatomical, Pathophysiological (CEAP) clinical class; Venous Clinical Severity Score (VCSS); Aberdeen Varicose Vein Questionnaire (AVVQ); periprocedural pain; and complications.
Results: 100% of the cases have been technically successful. At the 6-month follow-up, all treated SSVs were occluded. The 12-month assessment duplex doppler showed anatomical success in patients with 95.8% (95% confidence interval, 0.756-0.994). The CEAP clinical class, VCSS, and the AVVQ had decreased significantly at the 6- and 12-month follow-up, respectively.
Conclusions: EMWA and concomitant foam sclerotherapy is a feasible and effective technique for treating SSV insufficiency.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.avsg.2023.04.037 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ultrasound-guided foam sclerotherapy using physician-compounded foam: Position statement from the American vein and lymphatic society.
Phlebology
December 2024
Restoration Dermatology, Nashville, TN, USA.
Chronic venous disease has a major impact on the quality of life of millions of patients. Large randomized controlled trials have established ultrasound-guided foam sclerotherapy (UGFS) as a safe and effective treatment option for both saphenous vein insufficiency and tributary disease. Ultrasound guidance is a critical component of sclerotherapy of non-visible veins.
View Article and Find Full Text PDFA randomized controlled study to evaluate the safety and feasibility of concomitant transluminal injection of foam sclerosant combined with endovenous laser ablation in patients with incompetent small saphenous veins.
Phlebology
August 2024
Cardiovascular Center, Sakurabashi Watanabe Advanced Healthcare Hospital, Osaka, Japan.
Article Synopsis
- - The study aimed to compare the safety and effectiveness of transluminal foam sclerotherapy combined with endovenous laser ablation (EVLA) against EVLA alone for treating small saphenous vein incompetence, focusing on changes in the venous clinical severity score (VCSS) over one year.
- - Researchers conducted the study by using a sheath for foam sclerotherapy during the EVLA procedure, assessing various outcomes such as VCSS changes, reflux recurrence, and complications at multiple time points after treatment.
- - Results indicated that while the change in VCSS wasn't significantly impactful, the combination treatment (TLFS + EVLA) led to lower rates of residual or recurrent reflux compared to EVLA alone, suggesting TLFS
Totally endoscopic concomitant aortic and mitral valve surgery in junctional epidermolysis bullosa: a case report.
J Cardiothorac Surg
February 2024
Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, 650-0047, Japan.
Background: Junctional epidermolysis bullosa is a rare skin and mucosal disorder characterized by blister formation in response to minor trauma and extracutaneous manifestations. There have been no reports of cardiac surgery and prognostication in patients with epidermolysis bullosa due to skin and mucosal fragility.
Case Presentation: A 55-year-old man presented with congenital junctional epidermolysis bullosa, hypertension, and vasospastic angina.
Circular Polydiketoenamine Elastomers with Exceptional Creep Resistance via Multivalent Cross-Linker Design.
ACS Cent Sci
January 2024
Molecular Foundry Lawrence Berkeley National Laboratory 1 Cyclotron Road, Berkeley, California 94270, United States.
Elastomers are widely used in textiles, foam, and rubber, yet they are rarely recycled due to the difficulty in deconstructing polymer chains to reusable monomers. Introducing reversible bonds in these materials offers prospects for improving their circularity; however, concomitant bond exchange permits creep, which is undesirable. Here, we show how to architect dynamic covalent polydiketoenamine (PDK) elastomers prepared from polyetheramine and triketone monomers, not only for energy-efficient circularity, but also for outstanding creep resistance at high temperature.
View Article and Find Full Text PDFA Case of Anti-vascular Endothelial Growth Factor Therapy-Related Nephrotic Syndrome With Marked Intraglomerular Macrophage Infiltration.
Cureus
December 2023
Department of Nephrology, Saitama Medical University, Saitama, JPN.
Article Synopsis
- - A 75-year-old woman with colon cancer developed massive proteinuria after treatment with FOLFIRI and bevacizumab, leading to the discontinuation of only bevacizumab, which initially improved her condition.
- - More than six months later, she experienced a recurrence of proteinuria and declining kidney function, with a biopsy revealing damage due to chronic endothelial cell issues thought to be related to bevacizumab and other chemotherapy drugs.
- - Despite attempts to manage her condition through diet and antihypertensive therapy, the patient's ability to continue chemotherapy suffered, indicating that careful monitoring and management of related health issues are essential in cancer treatments to prevent renal complications.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!